A new vaccine for Europe
A new vaccine (“Nuvaxovid”) from the American biotech company Novavax has been approved by the European Medicines Agency (EMA).
A new vaccine (“Nuvaxovid”) from the American biotech company Novavax has been approved by the European Medicines Agency (EMA).